Karuna Therapeutics, Inc. KRTX

Full chart Compare
Set alert

Price alert · KRTX

All alert types
329.83 +329.83

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $63.47MExpenses → Gross Loss: $1.05MExpenses → Selling, General & Admin: $131.33MExpenses → Research & Development: $364.10MExpenses → Income Tax: $670.00KNet Loss → Expenses: $433.68MRevenue → Cost of Revenue: $654.00KOther Income$63.47MNet Loss$433.68MCost of Revenue$1.70MExpenses$497.15MGross Loss$1.05MSelling, General & Admin$131.33MResearch & Development$364.10MIncome Tax$670.00KRevenue$654.00K

Latest period ending Dec 31, 2023 · select a line to chart its full history

KRTX annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
654.00K10.64M36.96M00
654.00K10.64M36.96M00
-494.78M-289.68M-143.85M-71.82M-45.41M
-433.68M-276.34M-143.81M-68.55M-43.96M
-11.73-8.74-4.94-2.59-3.68
KRTX annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
185.82M248.59M207.21M53.20M209.05M
1.34B1.16B527.67M347.63M393.02M
81.97M37.10M25.64M8.69M3.11M
16.69M5.33M7.50M2.69M208.00K
1.25B1.13B502.03M338.93M389.92M
KRTX annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-385.82M-228.01M-100.88M-69.86M-30.92M
-160.32M-586.39M-22.69M-89.65M-174.34M
483.37M855.78M277.57M3.66M405.28M
-2.92M-915.00K-3.07M-419.00K-115.00K
-62.77M41.38M154.01M-155.85M200.03M